Anita Kidgell serves as a Non Executive Board Director at IP Group plc since January 2023 and has been with GSK since September 2008, currently holding the role of Senior Vice President, Corporate Strategy. In this capacity, Anita has led significant strategic initiatives, including a comprehensive review of ESG strategies and a 5-year blueprint for growth in China. Previous roles at GSK include Vice President of Corporate Strategy, where Anita oversaw enhancements in R&D pipelines and business valuations. Anita's earlier experience includes a directorship at Brunswick Group and leadership roles in investor relations and communications at GSK and GlaxoWellcome, with a foundational career in clinical research and discovery at GS Searle and Glaxo holdings. Anita holds a BSC Hons in Applied Biology from London.